Introduction:
We emphasise the role of imaging as illustrated by the case of a 71-year-old male who presented with acute pericarditis one day after receiving a Varicella Zoster Virus (VZV) Vaccination. Although active VZV infection itself is recognised as an uncommon trigger for pericarditis, and myopericarditis following several live attenuated vaccines, its occurrence specifically following VZV vaccination is rare.
Case Presentation:
This gentleman was previously fit and well prior with no significant comorbidity or drug allergies. Clinically, we suspected VZV vaccine-induced pericarditis in this case due to the short temporal relationship between vaccination and symptom onset and absence of other known infectious and non-infectious causes of pericarditis. This was in addition to characteristic chest pain, fever, sweating, electrocardiogram (clear PR depression and subtle concave ST elevation) and imaging (echocardiography and Cardiac MRI) features.
Imaging Results:
Pulmonary embolism was excluded by CT pulmonary angiography, but this scan did reveal a large, global pericardial effusion. Prompt transthoracic echocardiogram categorised the pericardial effusion as small and did not show any signs of cardiac tamponade. Cardiac MRI imaging demonstrated a large pericardial effusion but did not show any overt myocardial oedema, inflammation or fibrosis, consistent with a low high-sensitivity troponin I. Interestingly, the MRI did not reveal any convincing pericardial oedema or fibrosis acutely, which might be expected in pericarditis.
Transthoracic echocardiography was important in excluding features of tamponade and helped confirm the diagnosis of acute pericarditis by clearly demonstrating the pericardial effusion. A Cardiac MRI was essential in excluding co-existent myocarditis and infarction.
Conclusions:
Acute pericarditis should be considered in patients presenting with chest pain after receiving the VZV vaccination and patients should be made aware of this rare side effect prior to receiving their vaccination. The patient in this case study responded well to symptomatic treatment with analgesia and colchicine, suggesting that anti-viral therapy is not required for VZV related pericarditis.
Background and Aims: Acute Coronary Syndromes (ACS) represent a significant challenge for healthcare systems worldwide, however there is a vast disparity between developed and developing countries in terms of their management and subsequent patient outcomes. The aim of this reflective report was to explore the services provided for ACS patients in the developing country Nepal and compare them to the highly developed United Kingdom. This was with a view to summarise the priorities for Nepal going forward in addressing this major public health challenge and improving their ACS patient outcomes.Methods: This reflective report was constructed following an elective placement at the Shahid Gangalal National Heart Centre in Kathmandu, Nepal. It involved collecting numerous ACS patient case studies from the United Kingdom (UK) and Nepal and reflecting on their clinical experiences using the Gibbs Reflective Cycle.Reflective Summary: The treatment strategies for ACS are very similar in both countries, however in Nepal it is more difficult to efficiently transport patients into hospital and the population is less aware of the symptoms of ACS, thus contributing to delayed presentations and poorer outcomes. Furthermore, the provision of non-emergency healthcare, collection of patient data and general hospital resources were understandably deficient in comparison to the UK given the difference in financial status.Discussion: In order to address the rising incidence of ACS, Nepal should prioritise investment in the hospital facilities provided for these patients, including suitably equipped emergency transport and cardiac catheterisation laboratories. In addition, they should work towards an electronic patient database and more established non-emergency healthcare services. Perhaps most importantly is the need for improved health promotion about the risk factors for ACS and the signs of a heart attack.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.